A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

Completed

• Conditions: Spastic Hemiparesis; Muscle Spasticity

• Registration Number: NCT05546190
• Lead Sponsor: Ipsen

Brief Summary

The participants of this study will have AUL spasticity and have a need for botulinum toxin type A injections. AUL spasticity is where people develop tightening or stiffness of the muscles in the arms. Botulinum toxin type A is used for the treatment of spasticity in addition to physiotherapy. This study will ask participants to describe their experience living with AUL spasticity. This information will be used to assess the Arm Activity Measure (ArmA). ArmA is a scale designed to assess upper limb function in people with AUL spasticity. This study could suggest changes to the ArmA to improve its suitability for people with AUL spasticity or even the development of a new scale.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-09-16
• Study First Submitted QC: 2022-09-16
• Study First Posted: 2022-09-19
• Study Start: 2022-09-20
• Primary Completion: 2023-03-23
• Study Completion: 2023-03-23
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-14
• Last Update Posted: 2023-04-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants answering to the questionnaire: for Part 1 15/15 subject	First interview/ at baseline

Trial Locations

Locations (2)

Rancho Los Amigos National Rehab; 🇺🇸 Downey, California, United States

MedStar National Rehabilitation Network; 🇺🇸 Washington, District of Columbia, United States